Correspondingly, pharmacological activation of REV-ERBα has been reported to inhibit autophagy and induce apoptosis in cancer cells [17], impair insulin secretion, and promote cell apoptosis in β-cell lines [19]. This evidence concerns the gene NR1D1 and cancer.